![Kathy Galante](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathy Galante
Investor Relations Contact chez
IVERIC BIO, INC.
Profil
Kathy Galante is currently the Senior Vice President-Investor Relations at IVERIC bio, Inc. She previously worked as the Senior Director-Investor & Public Relations at OSI Pharmaceuticals, Inc. and as the Investor Relations Contact at ISTA Pharmaceuticals, Inc. In addition, she held the position of Senior Vice President at Burns McClellan, Inc. from 2011 to 2013.
Postes actifs de Kathy Galante
| Sociétés | Poste | Début |
|---|---|---|
| IVERIC BIO, INC. | Investor Relations Contact | 13/11/2013 |
Anciens postes connus de Kathy Galante
| Sociétés | Poste | Fin |
|---|---|---|
Burns McClellan, Inc.
 Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public and investor relations services | Corporate Officer/Principal | 01/11/2013 |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets ophthalmic pharmaceutical products | Public Communications Contact | - |
| OSI PHARMACEUTICALS, INC. | Public Communications Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets ophthalmic pharmaceutical products | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Burns McClellan, Inc.
Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public and investor relations services | Commercial Services |
